Clinical Trials Directory

Trials / Completed

CompletedNCT03756272

Stellate Ganglion Block to Reduce Hot Flushes

Short-term Efficacy of Stellate Ganglion Block to Reduce Hot Flushes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
76 (actual)
Sponsor
Rijnstate Hospital · Academic / Other
Sex
Female
Age
30 Years – 70 Years
Healthy volunteers
Accepted

Summary

To assess the short-term efficacy of stellate ganglion block on hot flush reduction versus sham procedure

Detailed description

Hot flushes are the most common symptom of menopause for which postmenopausal (PMP) women seek medical help, in 20% of PMP women hot flushes can persist for up to 15 years. A possible treatment for hot flushes is stellate ganglion block (SGB), used as a means to interrupt parts of the sympathetic nervous system involved in temperature regulation. Single centre randomized double blind placebo controlled intervention study Study period of 6 months in which patients will fill out on set time points 5 questionnaires regarding quality of life and keep a diary on hot flush frequency and severity during1 week on the same time points. Study population: Postmenopausal women aged 30-70 years old with no other causes of flushing present. Intervention (if applicable) Intervention: Stellate ganglion block versus sham procedure Follow up with questionnaires during 6 months.

Conditions

Interventions

TypeNameDescription
PROCEDUREBupivacaine blockstellate ganglion bupivacaine injection
PROCEDUREPlacebo ganglion blockstellate ganglion sodium chloride injection

Timeline

Start date
2017-09-01
Primary completion
2018-04-28
Completion
2019-02-01
First posted
2018-11-28
Last updated
2020-03-11

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT03756272. Inclusion in this directory is not an endorsement.